Works matching IS 02694727 AND DT 2021 AND VI 46 AND IP 2
Results: 41
Comment on: 'Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine' by Tsushita et al.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Enhanced external counterpulsation: A unique treatment for the "No‐Option" refractory angina patient.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 295, doi. 10.1111/jcpt.13330
- By:
- Publication type:
- Article
A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 286, doi. 10.1111/jcpt.13329
- By:
- Publication type:
- Article
Effective use of fondaparinux in patient with unresponsiveness to nadroparin.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 539, doi. 10.1111/jcpt.13328
- By:
- Publication type:
- Article
Utility of the respiratory viral panel as an antimicrobial stewardship tool.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 277, doi. 10.1111/jcpt.13326
- By:
- Publication type:
- Article
Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 532, doi. 10.1111/jcpt.13321
- By:
- Publication type:
- Article
Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 528, doi. 10.1111/jcpt.13317
- By:
- Publication type:
- Article
High‐level ceftaroline resistance in a paediatric patient with invasive methicillin‐resistant Staphylococcus aureus infection without previous ceftaroline exposure.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 524, doi. 10.1111/jcpt.13316
- By:
- Publication type:
- Article
Antiretroviral treatment leading to secondary trimethylaminuria: Genetic associations and successful management with riboflavin.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 304, doi. 10.1111/jcpt.13315
- By:
- Publication type:
- Article
Comparative efficacy and safety of glycerol versus mannitol in patients with cerebral oedema and elevated intracranial pressure: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 504, doi. 10.1111/jcpt.13314
- By:
- Publication type:
- Article
Acarbose bioequivalence: Exploration of eligible protocol design.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 492, doi. 10.1111/jcpt.13313
- By:
- Publication type:
- Article
Estimation of effective dose of propofol mono‐sedation for successful insertion of upper gastrointestinal endoscope in healthy, non‐obese Chinese adults.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 484, doi. 10.1111/jcpt.13312
- By:
- Publication type:
- Article
Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 519, doi. 10.1111/jcpt.13311
- By:
- Publication type:
- Article
The Zika virus: Lurking behind the COVID‐19 pandemic?
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 267, doi. 10.1111/jcpt.13310
- By:
- Publication type:
- Article
The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 256, doi. 10.1111/jcpt.13309
- By:
- Publication type:
- Article
Use of ICD‐10‐CM T codes in hospital claims data to identify adverse drug events in Taiwan.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 476, doi. 10.1111/jcpt.13308
- By:
- Publication type:
- Article
Analysis of the clinical characteristics of insulin autoimmune syndrome induced by methimazole.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 470, doi. 10.1111/jcpt.13307
- By:
- Publication type:
- Article
Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 460, doi. 10.1111/jcpt.13306
- By:
- Publication type:
- Article
Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID‐19.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 454, doi. 10.1111/jcpt.13305
- By:
- Publication type:
- Article
An individualized administration model of vancomycin in elderly patients with sepsis and factors influencing augmented renal clearance.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 447, doi. 10.1111/jcpt.13304
- By:
- Publication type:
- Article
Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 440, doi. 10.1111/jcpt.13303
- By:
- Publication type:
- Article
Propofol suppresses the His‐ventricular conduction in paediatric patients.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 433, doi. 10.1111/jcpt.13302
- By:
- Publication type:
- Article
Loading dose and efficacy of continuous or extended infusion of beta‐lactams compared with intermittent administration in patients with critical illnesses: A subgroup meta‐analysis and meta‐regression analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 424, doi. 10.1111/jcpt.13301
- By:
- Publication type:
- Article
Gastrointestinal events with PARP inhibitors in cancer patients: A meta‐analysis of phase II/III randomized controlled trials.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 241, doi. 10.1111/jcpt.13300
- By:
- Publication type:
- Article
Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 415, doi. 10.1111/jcpt.13299
- By:
- Publication type:
- Article
Association of prior fluoroquinolone treatment with survival outcomes of immune checkpoint inhibitors in Asia.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 408, doi. 10.1111/jcpt.13298
- By:
- Publication type:
- Article
Bone fractures during the time of coronavirus.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 543, doi. 10.1111/jcpt.13297
- By:
- Publication type:
- Article
Monitoring antimicrobial cross‐resistance with cross‐resistance rate correlation diagrams: Changes in antibiotic susceptibility of Pseudomonas aeruginosa due to hospital relocation.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 395, doi. 10.1111/jcpt.13296
- By:
- Publication type:
- Article
Development of a pharmacy 'patient prioritization tool' for use in a Tertiary Paediatric Hospital.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 388, doi. 10.1111/jcpt.13295
- By:
- Publication type:
- Article
Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib‐induced hypercholesterolaemia in patients with chronic myeloid leukaemia.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 382, doi. 10.1111/jcpt.13294
- By:
- Publication type:
- Article
Intravenous push versus intravenous piggyback beta‐lactams for the empiric management of gram‐negative bacteremia.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 373, doi. 10.1111/jcpt.13291
- By:
- Publication type:
- Article
Safety and feasibility of crushing sevelamer tablets for enteral feeding tube administration.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 369, doi. 10.1111/jcpt.13290
- By:
- Publication type:
- Article
Safety outcomes with high‐dose daptomycin in patients with acute kidney injury and/or end‐stage renal disease.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 363, doi. 10.1111/jcpt.13289
- By:
- Publication type:
- Article
A qualitative study exploring the lived experience of medication use in different disease states: Linking experiences of disease symptoms to medication adherence.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 352, doi. 10.1111/jcpt.13288
- By:
- Publication type:
- Article
A retrospective test for a possible relationship between linezolid‐induced thrombocytopenia and hyponatraemia.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 343, doi. 10.1111/jcpt.13287
- By:
- Publication type:
- Article
Evaluation of tacrolimus and mycophenolic acid removal by simultaneous continuous hemodiafiltration and plasma exchange in a lung transplant patient.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 515, doi. 10.1111/jcpt.13286
- By:
- Publication type:
- Article
Development of LC‐MS/MS determination method and backpropagation artificial neural networks pharmacokinetic model of febuxostat in healthy subjects.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 333, doi. 10.1111/jcpt.13285
- By:
- Publication type:
- Article
Cilostazol increases adenosine plasma concentration in patients with acute coronary syndrome.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 328, doi. 10.1111/jcpt.13284
- By:
- Publication type:
- Article
Prospective study of the effect of sulfotanshinone sodium combined with tirofiban on vascular endothelial function and indicators of plaque stability in elderly patients with acute coronary syndrome.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 319, doi. 10.1111/jcpt.13283
- By:
- Publication type:
- Article
Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non–small‐cell lung cancer patients: A network meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. 310, doi. 10.1111/jcpt.13281
- By:
- Publication type:
- Article
Issue information.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 2, p. i, doi. 10.1111/jcpt.13185
- Publication type:
- Article